11:06:06 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2024-10-24 Kvartalsrapport 2024-Q3
2024-07-12 Kvartalsrapport 2024-Q2
2024-05-17 Ordinarie utdelning ICO 0.00 SEK
2024-04-25 Kvartalsrapport 2024-Q1
2024-03-06 Extra Bolagsstämma 2024
2024-02-29 Bokslutskommuniké 2023
2023-10-27 Extra Bolagsstämma 2023
2023-10-27 Kvartalsrapport 2023-Q3
2023-07-14 Kvartalsrapport 2023-Q2
2023-05-23 Ordinarie utdelning ICO 0.00 SEK
2023-05-22 Årsstämma 2023
2023-04-28 Kvartalsrapport 2023-Q1
2023-02-17 Bokslutskommuniké 2022
2022-10-28 Kvartalsrapport 2022-Q3
2022-07-15 Kvartalsrapport 2022-Q2
2022-05-19 Ordinarie utdelning ICO 0.00 SEK
2022-05-17 Årsstämma 2022
2022-04-29 Kvartalsrapport 2022-Q1
2022-02-18 Bokslutskommuniké 2021
2021-10-28 Kvartalsrapport 2021-Q3
2021-08-20 Kvartalsrapport 2021-Q2
2021-05-20 Ordinarie utdelning ICO 0.00 SEK
2021-05-19 Årsstämma 2021
2021-04-29 Kvartalsrapport 2021-Q1
2021-02-17 Bokslutskommuniké 2020
2020-10-27 Kvartalsrapport 2020-Q3
2020-08-19 Kvartalsrapport 2020-Q2
2020-05-11 Ordinarie utdelning ICO 0.00 SEK
2020-05-08 Kvartalsrapport 2020-Q1
2020-05-08 Årsstämma 2020
2020-03-11 Extra Bolagsstämma 2020
2020-02-14 Bokslutskommuniké 2019
2019-10-25 Kvartalsrapport 2019-Q3
2019-08-16 Kvartalsrapport 2019-Q2
2019-05-16 Ordinarie utdelning ICO 0.00 SEK
2019-05-15 Årsstämma 2019
2019-04-25 Kvartalsrapport 2019-Q1
2019-02-14 Bokslutskommuniké 2018
2018-11-09 Kvartalsrapport 2018-Q3
2018-08-10 Kvartalsrapport 2018-Q2
2018-05-16 Årsstämma 2018
2018-04-19 Kvartalsrapport 2018-Q1

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Iconovo är verksamt inom medicinteknik. Bolaget utvecklar inhalatorer för medicinskt bruk. Bolagets produkter används vid behandling utav astma och kol, där inhalatorerna består av pulverbaserat läkemedel. Produkterna licensieras ut och säljs under varierade varumärken. Utöver produktutveckling återfinns kompetens inom läkemedelsformulering. Bolaget grundades under 2013 och har sitt huvudkontor i Lund.
2021-11-15 12:00:00

At the Annual General Meeting of 8 May 2020, it was resolved that Iconovo shall have a Nomination Committee consisting of four members representing the four largest shareholders as of 30 September each year.

The Nomination Committee for the 2022 Annual General Meetings consists of:

Mats Johansson, appointed by Mats Johansson and holding company, and Chairman of the Nomination Committee

Karin von Wachenfeldt, appointed by Lastow Consulting AB;

Stefan Berger, appointed by Eiffel Investment Group;

Sussi Kvart, appointed by Handelsbanken Fonder

Participates as co-opted;

Gunnar Gårdemyr, Chairman of the Board

The Nomination Committee’s overarching responsibility for the 2022 Annual General Meeting is to present suitable candidates for the positions of Board Chair, Board members and auditor(s) of the Company, and to propose their remuneration.

The Nomination Committee shall prepare proposals in the following matters to be submitted to the Annual General Meeting for decision:

proposal for Chair of the AGM,

proposal for the number of AGM-elected Board members and, where applicable, number of auditors,

proposal for remuneration to non-employed members of the Board and to non-employed members of the various committees of the Board,

proposal for remuneration to the auditors,

proposals for election of Board Chair, other members of the Board and, where applicable, auditors,

proposals for guidelines for appointing members to the Nomination Committee and for the Nomination Committee’s assignments,

proposal for remuneration to the members of the Nomination Committee.

 

Shareholders who wish to submit proposals to the Nomination Committee can contact the Nomination Committee by email at gunnar.gardemyr@gmail.com.

In order for the Nomination Committee to process received proposals with sufficient care, these should be received by the Nomination Committee by 1 March 2022.